Australia Isothermal Nucleic Acid Amplification Technology Market Size & Outlook

Name: Australia Isothermal Nucleic Acid Amplification Technology Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The isothermal nucleic acid amplification technology market in Australia is expected to reach a projected revenue of US$ 284.1 million by 2030. A compound annual growth rate of 12.9% is expected of Australia isothermal nucleic acid amplification technology market from 2024 to 2030.

Clinical Diagnostics
- In Vitro Diagnostics
  - Isothermal Nucleic Acid Amplification Technology Market Outlook

Australia isothermal nucleic acid amplification technology product outlook (Revenue, USD million, 2018-2030)
- Instruments
- Reagent
Australia isothermal nucleic acid amplification technology technology outlook (Revenue, USD million, 2018-2030)
- NASBA
- HDA
- LAMP
- SDA
- SPIA
- NEAR
- TMA
- RCA
- RPA
- SMAP2
- Others
Australia isothermal nucleic acid amplification technology application outlook (Revenue, USD million, 2018-2030)
- Blood Screening
- Infectious Disease Diagnostics
- Cancer
- Others
Australia isothermal nucleic acid amplification technology end-use outlook (Revenue, USD million, 2018-2030)
- Hospitals
- Central and Reference Labs
- End-use

Australia Isothermal Nucleic Acid Amplification Technology Market Size & Outlook

Data Tree

Sign up - it's easy, and free!